DL-Propargylglycine is a non-proteinogenic amino acid derivative featuring a side chain bearing a terminal propargyl (alkyne) group attached to the alpha carbon, with both an amino group and a carboxyl group on the amino acid backbone. The "DL" designation indicates a racemic mixture of stereoisomers at the alpha stereocenter, and the molecule's alkyne functionality provides a chemical handle for selective derivatization while the amino and carboxyl groups support salt formation and standard amino acid coupling chemistry. DL-Propargylglycine is used in peptide and amino-acid chemistry workflows to introduce an alkyne-bearing residue or to prepare chemically defined conjugation and labeling intermediates for structure-activity studies, chemical biology probes, and analytical method development.
CAT No: CP08903
CAS No:64165-64-6
Synonyms/Alias:64153-47-5;gamma-Carboxy-D-glutamic-acid;1,1,3-Propanetricarboxylicacid,3-amino-,(3R)-;AmbotzHAA1020;AC1OE4FY;C4272_SIGMA;gamma-CarboxyD-glutamicacid;gamma-Carboxy-D-glutamicacid;SCHEMBL4303994;CTK2F2756;MolPort-003-940-734;ZINC2004604;AKOS006345204;D-CYSTEINEHYDROCHLORIDEMONOHYDRATE;DB-054618;FT-0640929;(3R)-3-aminopropane-1,1,3-tricarboxylicacid
DL-Propargylglycine is a DL mixture of the propargyl-substituted amino acid, featuring a stereogenic α-carbon bearing a free carboxylic acid and a primary amino functionality (or a corresponding salt form depending on handling). The side chain contains a terminal alkyne, enabling orthogonal reactivity for click-type conjugation and for selective derivatization without disturbing the amino acid backbone. The propargyl group provides a handle for functional group transformation into amides, triazoles, or other alkyne-derived motifs, while the amino and carboxyl groups support standard peptide coupling and protection-group strategies. As a chiral amino acid intermediate in racemic form, DL-Propargylglycine can be used to access both stereochemical configurations during library synthesis, SAR studies, and downstream peptidomimetic construction.
1. Peptide Coupling
DL-Propargylglycine is applied in peptide synthesis and peptidomimetic construction where the amino acid backbone participates in amide bond formation, typically after conversion to an N-protected derivative and activation of the carboxyl group. The terminal alkyne side chain remains chemically addressable under many peptide-coupling conditions, supporting post-coupling functionalization such as alkyne-to-triazole formation for molecular tagging. Racemic stereochemistry allows parallel access to both configurations at the α-center, which can be useful for mapping stereochemical effects in short peptide analog series. DL-Propargylglycine therefore functions as a practical amino acid building block for generating alkyne-bearing peptide fragments and for producing intermediates that can be further elaborated into bioactive or probe-like scaffolds.
2. Chemical Biology Probes
DL-Propargylglycine is used in chemical biology workflows that require an amino acid-derived alkyne handle for affinity labeling and modular probe construction. The terminal alkyne enables orthogonal conjugation chemistry, including copper-catalyzed azide-alkyne cycloaddition to install fluorescent tags, affinity groups, or solubilizing handles onto peptide or protein targets. The presence of both the amino acid functionality and the propargyl side chain supports incorporation into labeled peptides, enzyme substrates, or small-molecule conjugates prior to conjugation steps. DL-Propargylglycine thus supports downstream biomolecule labeling strategies and the preparation of alkyne-functional intermediates for mechanistic studies.
3. Amino Acid Derivatization
DL-Propargylglycine is employed as an amino acid derivatization intermediate for building functionalized derivatives that retain the propargyl group while transforming the amino and/or carboxyl functionality. The carboxylic acid can be converted into activated esters or amides, while the amino group can be protected to control chemoselectivity during multi-step syntheses, including routes that generate N-protected amino acid derivatives for peptide coupling compatibility. Terminal alkyne reactivity can be leveraged to form heterocycles or to introduce substituents that modulate polarity, binding, or stability of the resulting analogs. DL-Propargylglycine therefore serves as a chiral amino acid intermediate for preparing alkyne-bearing building blocks used in synthetic organic chemistry and in the assembly of complex molecular scaffolds.
4. SAR And Peptidomimetics
DL-Propargylglycine is applied in structure-activity relationship studies and peptidomimetic design where stereochemical variation and side-chain functionalization are key variables. The propargyl side chain provides a chemically persistent motif that can be transformed into triazole-containing linkers or other alkyne-derived pharmacophore surrogates after incorporation into a scaffold. The α-amino acid core supports systematic substitution of N- and C-terminal protecting groups, enabling consistent peptide analog construction across a series of compounds. DL-Propargylglycine's racemic nature can be used to generate mixed-stereochemistry libraries for early SAR mapping, with subsequent stereochemical refinement when needed for lead optimization.
5. Process Chemistry Intermediate
DL-Propargylglycine is suitable for process chemistry intermediate preparation in fine chemical synthesis due to its straightforward amino acid functionality and a terminal alkyne that can be carried through manufacturing sequences as a stable, late-stage functional handle. The amino acid backbone supports established protection-group strategies for controlling reactivity during scale-up, while the propargyl group can be preserved for downstream conjugation or derivatization steps that occur after scaffold assembly. Industrially relevant routes can incorporate conversion to N-protected forms and carboxyl-activated intermediates used for peptide building block preparation, followed by controlled functional group transformations on the side chain. DL-Propargylglycine therefore can be employed as an industrial amino acid-based intermediate for producing alkyne-functional specialty chemicals and for enabling scalable manufacture of peptide-like intermediates.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.